CJC-1295 and ipamorelin are the classic "paired" peptides in growth-hormone research — and the reason they're paired is exactly that they're different. Each pulls a separate lever on the same system. Understanding the two levers is the whole comparison.
The one-line difference
Your body has two ways to trigger a growth-hormone pulse. CJC-1295 copies one of them (the GHRH "release" signal). Ipamorelin copies the other (the ghrelin trigger). Different buttons, same machine.
Two mechanisms, one system
| CJC-1295 | Ipamorelin | |
|---|---|---|
| Class | GHRH analog | Ghrelin-receptor (GHS) agonist |
| Lever it pulls | GHRH receptor | GHS/ghrelin receptor |
| Reported half-life | Days (DAC form) | ~2 hours |
| Evidence base | Human pharmacokinetic data | Mostly preclinical |
| Defining trait | Long-acting | Selective (clean hormone profile) |
- CJC-1295 mimics growth-hormone-releasing hormone (GHRH) — the brain's direct "release growth hormone" order. In its DAC form it's engineered to last for days1 (the crucial DAC detail is in CJC-1295 DAC vs no-DAC).
- Ipamorelin activates the ghrelin/GHS receptor — a separate trigger — and is prized for doing so "selectively," without the cortisol spike older peptides caused2.
Because they pull two different levers, the research rationale for combining them is complementary, not redundant: two triggers together can produce a bigger, more natural growth-hormone pulse than either on its own.
What the studies actually found
Note the model — and how uneven the evidence is between the two:
| Study | Model | Key result | Year |
|---|---|---|---|
| Raun et al.2 | Rat, pig + cells (ipamorelin) | Released growth hormone as strongly as GHRP-6 but without raising cortisol — the "selective" result | 1998 |
| Teichman et al.1 | Human (healthy adults, CJC-1295 DAC) | A single injection raised growth hormone for 6+ days and IGF-1 for 9–11 days; half-life 5.8–8.1 days | 2006 |
In plain terms: CJC-1295 has been measured in people; ipamorelin's headline evidence is from animals. That's an honest asymmetry worth knowing before treating the pair as equally proven.
The half-life mismatch
This is the most practical contrast. CJC-1295 (DAC) persists for days; ipamorelin clears in ~2 hours. So even when studied as a pair, they behave on completely different timelines — ipamorelin a brief pulse, CJC-1295 a days-long background (CJC-1295 curve, ipamorelin curve).
The honest bottom line
The mechanistic pairing is real and sensible: two complementary levers on the growth-hormone system. But keep two facts in view — the evidence is uneven (human PK for CJC-1295, preclinical for ipamorelin), and neither is an approved medicine; both sit inside the FDA's ongoing 503A compounding review3. No completed human trial has tested the combination for a specific benefit.
Where to go deeper
What is CJC-1295, what is ipamorelin, and the broader growth-hormone secretagogues explainer cover each mechanism in full.